Navigation Links
Medco to Present at the Citi 2011 Global Health Care Conference
Date:2/28/2011

FRANKLIN LAKES, N.J., Feb. 28, 2011 /PRNewswire/ -- David B. Snow Jr., chairman and chief executive officer, Medco Health Solutions, Inc. (NYSE: MHS), is scheduled to address the Citi 2011 Global Health Care Conference in New York on Tuesday, March 1, 2011.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

The presentation at the Hilton, New York, will begin at 8 a.m. ET.  Richard J. Rubino, Medco's chief financial officer, is also scheduled to attend.

The presentation may be heard live via a simulcast link and the accompanying slides will be available at www.medco.com/investor.  Real Player or Windows Media Player is required to listen to the webcast.  Free downloads of both players are available at the webcast site.  The webcast will be available for replay for one month following the presentation.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2010 revenues of nearly $66 billion, Medco ranks 35th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.    


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
2. Medco Announces Date for Release of Fourth-Quarter and Full-Year 2010 Financial Results
3. Medco CEO to Present at Upcoming Healthcare Conferences
4. Medco Extends URAC Accreditation to Drug Therapy Management, PBM
5. Medcos 2011 National Medicare Prescription Drug Plan (PDP) Earns CMS 5-Star Quality and Performance Rating
6. Medco to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
7. Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks
8. Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevadas Future
9. Medco Announces Date for Third-Quarter 2010 Financial Results
10. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
11. Medco Issues $1.0 Billion of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the ... and Chief Executive Officer (CEO) and member of the Board ... Richard Love , interim President and CEO who will continue ... has over 20 years of experience in hematology, oncology and ... . "On behalf of CTI BioPharma,s Board, ...
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets ... and Strategies - 2016" report to their offering. ... The latest research Dry eye Drugs Price ... the global Dry eye market. The research answers the following questions: ... Dry eye and their clinical attributes? How are they positioned in the ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... ... Guajardo Carothers is not your typical author. She went from working as a movie extra ... about God, when she isn’t swimming as a performing mermaid. , Her book isn’t typical ... she offers a comedic look at the dysfunctions of God’s family, before Lucifer was sent ...
(Date:2/27/2017)... ... ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme and Associated ... Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) dismiss any ... into a single volume a compelling argument that the disease does exist in his ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Francisco and environs, is proud to announce an upgrade to the company's Yelp ... upgraded Yelp page on topics as diverse as Platelet Rich Plasma (PRP) therapy, ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... in staffing, scheduling, and reporting for healthcare organizations. This comprehensive and customizable ... entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects ...
Breaking Medicine News(10 mins):